These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11522862)

  • 1. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
    Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy.
    Melk A; Daniel V; Mehls O; Opelz G; Tönshoff B
    Transplantation; 2004 Dec; 78(12):1792-801. PubMed ID: 15614153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone as a new treatment modality for short children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Mehls O; Haffner D; Wühl E; Tönshoff B; Schaefer F; Heinrich U
    Horm Res; 1996; 46(4-5):230-5. PubMed ID: 8950626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
    Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
    Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and the kidney: the use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency.
    Fine RN
    J Am Soc Nephrol; 1991 Apr; 1(10):1136-45. PubMed ID: 1768809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with recombinant human growth hormone (rhGH) in children with chronic kidney failure or renal transplantation].
    Crosnier H; Guest G; Souberbielle JC; Broyer M; Rappaport R
    Arch Pediatr; 1994 Aug; 1(8):716-22. PubMed ID: 7842104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic mechanisms underlying the variable response to recombinant human growth hormone in children with chronic renal failure.
    Schaefer F
    Br J Clin Pract Suppl; 1996 Aug; 85():23-5. PubMed ID: 8995024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D; Nissel R; Wühl E; Schaefer F; Bettendorf M; Tönshoff B; Mehls O
    Pediatr Res; 1998 Feb; 43(2):209-15. PubMed ID: 9475286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma growth hormone-binding activity is low in uraemic children.
    Postel-Vinay MC; Tar A; Crosnier H; Broyer M; Rappaport R; Tönshoff B; Mehls O
    Pediatr Nephrol; 1991 Jul; 5(4):545-7. PubMed ID: 1911135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B; Ziółkowska H; Majcher A; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():153-5. PubMed ID: 16898517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
    Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
    Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.
    Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O
    Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy.
    Hanekom WA; Hussey GD; Hughes EJ; Potgieter S; Yogev R; Check IJ
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):204-8. PubMed ID: 10066655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of growth hormone on growth and blood urea levels in children with chronic renal failure.
    McMahon KA; Powell HR; Walker RG; Jones CL
    J Paediatr Child Health; 1994 Jun; 30(3):230-3. PubMed ID: 8074908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.
    Ulinski T; Cochat P
    Pediatr Nephrol; 2006 Jul; 21(7):903-9. PubMed ID: 16773400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.